The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site. Please see our Subscription Terms and Conditions.


All material subject to strictly enforced copyright laws. © 2021 Euromoney, a part of the Euromoney Institutional Investor PLC.
Opinion

Getting a high return

For some of the highest returns around, the best bet is to invest in weed. Seattle-based firm Privateer Holdings is a private equity fund investing in industries that derive their business from medical marijuana.


 

The firm’s most recent investment is in Leafly – a data provider to medical-marijuana users that provides information on strains of cannabis and where to buy it legally. Leafly’s revenues are growing at 25% a month. By 2016, the remaining 32 US states that have not legalized the use of medical marijuana are expected to have done so. Brendan Kennedy, Privateer’s founder and chief executive, estimates the industry’s value at some $40 billion. Kennedy also says that investments in medical marijuana are seen as supporting a beneficial cause.

The majority of Americans are in favour of medical marijuana. He says: “Where the opportunity lies is as the industry becomes clean, transparent and informative – no longer associated with clichés such as The Grateful Dead, Snoop Dogg or Willie Nelson, but rather a place where it is not difficult for a 65-year-old woman to obtain cannabis for glaucoma.

"And that is where the industry is heading.”

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree